Trieza Therapeutics
Cambridge, US · Founded 2016 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
DC
David CordoExecutive
DH
Board
LE
Investors · 2
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 rounds · 2016
▶$6MraisedDec 2016 · 5 investors · PharmaceuticalsRule 506(b)
▶$6MraisedDec 2016 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- David CordoExecutive Officer
- Daniel HicklinExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$1raisedDec 2016 · 5 investors · PharmaceuticalsRule 506(b)
▶$1raisedDec 2016 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Luke EvninDirector
- David CordoExecutive Officer
- Daniel HicklinExecutive Officer, Director
- Offering amount
- $1
- Amount sold
- $1
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Trieza Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Trieza Therapeutics's investors?
- Trieza Therapeutics's investors include Astellas Venture Management LLC, MPM BioImpact.
- How much funding has Trieza Therapeutics raised?
- Trieza Therapeutics has disclosed $6M raised across 2 rounds.
- Where is Trieza Therapeutics headquartered?
- Trieza Therapeutics is headquartered in Cambridge, US.